SCHEMBL28795243

SCHEMBL28795243

COc1cc(N2CCC(N3CCN(CC4CCNCC4)CC3)CC2)c(C)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 1/20 0.40
GAA P10253 2/20 0.39
ACHE P22303 2/20 0.38
KMT2A Q03164 2/20 0.38
HTR4 Q13639 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 4/20 0.37
KDM4E B2RXH2 3/20 0.37
LMNA P02545 2/20 0.36
HTR6 P50406 1/20 0.36
MAPK1 P28482 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
FGFR3 P22607 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29803399 1.00 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HTTGAAACHE
SCHEMBL29803041 0.96 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HTTGAAACHE
SCHEMBL28795175 0.96 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2HTTGAAACHE
SCHEMBL28795155 0.95 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HTTGAAKMT2A
SCHEMBL29803421 0.95 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2HTTGAAKMT2A
SCHEMBL29803100 0.92 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HTTGAAACHE
SCHEMBL28795367 0.92 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2HTTGAAACHE
SCHEMBL28795166 0.90 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HTTGAAKMT2A
SCHEMBL29803033 0.90 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2HTTGAAKMT2A
SCHEMBL28795370 0.90 ACHE (0.41) ALDH1A1SMN1; SMN2HTTGAAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805303-A Molecule with double functions of degrading EGFR (epidermal growth factor receptor), composition and pharmaceutical application thereof 海思科医药集团股份有限公司 2022-07-29 CN disclosed